Jason Gale
Jason Gale covers the front line where infectious disease, health systems and global health security meet for Bloomberg, focusing on how dangerous pathogens test the resilience of care and preparedness. He reports on Ebola, pandemic influenza and other high-consequence threats alongside the policies, clinical trials and technologies designed to contain them. His recent work traces how outbreaks in places such as Congo and Uganda disrupt basic services, reshape international responses and raise broader questions for biosecurity and medical science.
Ebola and High-Consequence Outbreaks
Ebola is a central thread in Gale’s current reporting, and he follows the Bundibugyo strain outbreak in Congo in granular detail, from early case counts through mounting death tolls and the launch of experimental treatment trials.
He writes on patients receiving monoclonal antibodies and antivirals in adaptive platform trials, explaining how these studies are structured to keep running across future outbreaks when epidemics end before definitive results are in. He reports when health workers themselves are infected and evacuated for care, describing the protocols around transferring a Doctors Without Borders staff member to the Netherlands after testing positive for Bundibugyo virus disease.
His coverage tracks escalating numbers in Congo and neighboring countries as cases pass milestones in the hundreds and then thousands, tying those figures to overwhelmed treatment centers and the difficulties of surveillance and contact tracing in conflict-affected regions.
Beyond individual stories, Gale builds a continuous narrative about Ebola’s evolution in this outbreak, returning to the same provinces and health zones as conditions change. He reports on flights being halted and supplies running thin as the epidemic spreads across more health zones, showing how logistics and access shape the trajectory of the response.
He also brings in regional dynamics, covering Uganda’s confirmation of new Ebola cases, including infections in a health worker and a driver, and explaining how cross-border movement complicates containment. Across these pieces, outbreaks are never just numbers; they are linked to decisions by agencies, governments and humanitarian groups in real time.
Health Systems Strain and Essential Services
A defining feature of Gale’s work is the way he treats outbreaks as stress tests for basic health care, not only as virology stories. He documents how Ebola in Congo is hollowing out routine services, reporting sharp falls in the use of essential health services and in childhood vaccination rates in the hardest-hit areas. His pieces describe pregnant patients avoiding maternity care, families skipping pediatric clinics and communities staying away from health facilities altogether because of fear and the pressures on hospitals.
He connects these disruptions to the widening toll of the epidemic, showing that the impact extends far beyond those directly infected with the virus.
This systems lens shows up in his coverage of frontline health workers and the wider health infrastructure around them. Gale reports on infections among staff and the consequences for staffing and patient care, linking individual cases to already stretched facilities. He brings in analysis from humanitarian research groups to quantify declines in service use, using those figures to illustrate how an epidemic can reverse progress on immunization and maternal health within months.
Through this work, he positions Ebola as a catalyst for wider breakdowns in basic care, which matters for anyone looking at the secondary effects of crises on health systems.
Global Health Security, Policy and Research
Gale’s beat extends from outbreak scenes to the institutions and rules that govern global health security. He has covered pandemic influenza in depth, including a sustained run of reporting on swine flu that followed the emergence, worldwide spread and social and economic impact of the first influenza pandemic in more than four decades. His long tenure on the health beat is marked by more than 25 years at Bloomberg, focusing on infectious diseases and global health issues after early coverage of medical science during the H5N1 avian influenza outbreak.
That experience informs his current reporting on how agencies and governments rewrite global health rules in response to Covid and other threats.
His recent work for Bloomberg’s policy and science verticals includes stories on cuts to major health research grants that destabilize clinical trials, efforts by the US to redefine global health rules through new draft pacts, and studies tracking China’s rise in global science output relative to the US. He reports on advances at the intersection of oncology and immunology, such as research suggesting Covid mRNA vaccines may bolster cancer therapies and new experimental treatments joining the arsenal against prostate cancer.
These pieces show Gale moving between laboratories, funding bodies and international negotiations, treating health security as a system that spans pathogens, technology and governance.
Gender, Chronic Disease and Long-Running Health Themes
Alongside acute outbreaks, Gale has a record of reporting on long-running health challenges, including chronic diseases and gendered health risks. His work has examined the dangers around childbirth and the conditions that make the day of birth one of the riskiest in many parts of the developing world. He has written on how stigma around HIV leads women to hide their status, undermining progress on AIDS and complicating efforts to provide care and prevention for females and girls.
His broader portfolio has also covered diabetes, cancer and sanitation, reflecting a sustained interest in the structural factors that drive health outcomes over time.
This mix of acute and chronic themes, combined with his focus on biosecurity, positions Gale as a health reporter who bridges outbreak coverage, health systems analysis and the science and policy that sit behind them. His work gives equal weight to the pathogen, the patient and the institutions charged with protecting them.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.